Drug Therapy: Clinical Trials

27 trials for Drug Therapy, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

11 completed, 10 unknown, 4 recruiting, 2 not yet recruiting. 10 Phase 2, 3 Not applicable, 2 Phase 3, 2 Phase 4.

By phase and status

PhaseTrialsStatus
Phase 210Unknown 6, Completed 2, Recruiting 2
Not applicable3Completed 2, Unknown 1
Phase 32Completed 2
Phase 42Recruiting 1, Unknown 1

Follow this condition Literature Review of Drug Therapy trials Research Report on Drug Therapy

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Analysis of Efficacy and Outcomes of Immunotherapy for Malignant Tumors: A Prospective Non-interventional Clinical Study
Neoplasms, Drug Therapy
Not yet recruitingSichuan University5002026-06-302026-06-24
Efficacy of Trazodone to Treat Insomnia in Older Adults (TRADITION Study)
Trazodone 25 mg - Insomnia Chronic, Older People
Phase 2RecruitingCentre hospitalier de l'Université de Montréal (CHUM)402025-11-102025-12-08
Effects of Podcast Education on Medication Perception, Stigma Level, and Epilepsy Self-management in Epilepsy Patients
epilepsy education via podcast - Epilepsy, Stigma
Not applicableCompletedIstanbul Sabahattin Zaim University702024-11-252025-07-29
Efficacy and Resistant Mechanism of Eribulin and Bevacizumab for Advanced HER2 Negative Breast Cancer
Eribulin, Bevacizumab - Breast Neoplasms, Neoplasm Metastasis
Phase 2UnknownWang Jiayu602024-08-012024-08-06
Phase II Trial of Neoadjuvant Chemotherapy (NAC) Alone or in Combination With Immunotherapy Vaccine PRGN-2009 in Subjects With Newly Diagnosed HPV-Associated Oropharyngeal (Head and Neck) Cancer
Docetaxel, Cisplatin, PRGN-2009 - Squamous Cell Carcinoma of the Head and Neck, Oropharynx
Phase 2RecruitingNational Cancer Institute (NCI)702024-06-102026-10-19
Efficacy and Safety of Trifluridine/Tipiracil Combined With Fufuquitinib for Third-line Treatment of mCRC
trifluridine/tipiracil combined with fufuquitinib, fufuquitinib, Trifluridine/tipiracil - Metastatic Colorectal Cancer, Drug Therapy
Phase 2UnknownFirst Affiliated Hospital of Wenzhou Medical University2002024-03-012024-07-03
Efficacy of IST Combined With TPO-RA in the Treatment of AA and Establishment of a Recurrence Prediction System
CsA+ATG+Herombopag, CsA+Herombopag - Aplastic Anemia, CSA
Phase 4UnknownPeking Union Medical College Hospital2102023-01-202023-08-24
Effect of Chronotherapy on Blood Pressure - Time of Intake of Blood Pressure Lowering Drugs
Time of ordinary antihypertensive medication intake - Hypertension, Drug Therapy
Not applicableUnknownVastra Gotaland Region1202022-06-252024-08-20
"Extended" (Alternate Day) Antipsychotic Dosing
Risperidone, Olanzapine, paliperidone - Schizophrenia and Related Disorders, Drug Administration Schedule
Phase 4RecruitingCentre for Addiction and Mental Health1202022-06-062026-04-13
Registry Study of Pharmacotherapy and Clinical Outcomes in Elderly Patients With Coronary Heart Disease (PHARM-ageing)
Elderly Patients, Coronary Heart Disease
UnknownBeijing Anzhen Hospital150002022-02-012022-02-18
Effects of Anesthetic Techniques on Time to Start of Adjuvant Chemotherapy Following Surgery for Colorectal Cancer
Colorectal Neoplasms, Anesthesia
CompletedEuropean Society of Anaesthesiology55002021-12-012024-04-10
Pharmacokinetics of Meropenem and Aztreonam After Intraperitoneal Administration Via Cycler-therapy in APD Patients Without Peritonitis
Meropenem 1000 mg, Aztreonam 2000 mg, automated peritoneal dialysis with following long time dwell - Peritoneal Dialysis Associated Peritonitis, Peritoneal Dialysis (PD)
Phase 2 / Phase 3CompletedKarl Landsteiner Insitute for Nephrology and Haemato-Oncology122021-08-312025-08-11
Post-fracture Medication and Mortality
Anti-osteoporosis medications - Osteoporosis, Osteoporosis Fracture
CompletedNational Cheng-Kung University Hospital2161552020-11-012023-04-04
Safety Analysis of Antimicrobial Pharmacotherapy in Intensive Care Unit at Pediatric Hospital
Pharmacogenetic test - Drug Therapy
CompletedAnna Vlasova1002020-02-012022-03-18
Adjunct Phentermine + Topiramate After Bariatric Surgery in 12-24 Year Olds
Phentermine, Immediate Release Topiramate, Placebo for Phentermine - Obesity, Morbid, Bariatric Surgery
Phase 2CompletedUniversity of Colorado, Denver132020-01-152025-05-23
Registry Study on Drug Therapy and Clinical Outcomes in Patients With Acute Coronary Syndrome
Drug Therapy, Acute Coronary Syndrome
Not yet recruitingBeijing Anzhen Hospital100002019-12-012019-12-03
Potential Therapeutic Response In Urogenital Tumors
Biopsy - Urogenital Neoplasms, Drug Therapy
CompletedUniversity of Campinas, Brazil302019-01-022022-07-08
Comparison of Two Management Systems in Patients With Type 1 Diabetes (Pediatric SmartHome)
Medtronic MiniMed 670G Insulin Pump in Auto Mode, Medtronic MiniMed 670G Insulin Pump without Auto Mode - Patient Care, Drug Therapy
Not applicableCompletedKinderkrankenhaus auf der Bult402018-11-192021-06-16
Neoadjuvant FOLFOXIRI Chemotherapy in Resectable Liver Metastasis of Colorectal Cancer
FOLFOXIRI - Colorectal Neoplasms, Drug Therapy
Phase 2UnknownChina Medical University, China302018-05-012021-04-19
Neoadjuvant FOLFOXIRI Chemotherapy in Patients With Locally Advanced Colon Cancer
FOLFOXIRI - Colonic Neoplasms, Drug Therapy
Phase 2UnknownChina Medical University, China302018-04-012021-04-19

Showing 20 of 27. Sign in to see all of them.

Narrower conditions

Colorectal Neoplasms (3)  ·  Neoplasms (3)  ·  Breast Neoplasms (2)  ·  Acute Coronary Syndrome (1)  ·  Anemia, Aplastic (1)  ·  Carcinoma, Non-Small-Cell Lung (1)  ·  Colonic Neoplasms (1)  ·  Coronary Disease (1)  ·  Diabetes Mellitus, Type 1 (1)  ·  Epilepsy (1)  ·  Hepatitis C (1)  ·  Hypertension (1)  ·  Kidney Failure, Chronic (1)  ·  Lung Neoplasms (1)  ·  Lymphoma (1)

Broader conditions

Neoplasms (11)  ·  Neoplasms by Site (10)  ·  Digestive System Diseases (7)  ·  Digestive System Neoplasms (5)  ·  Gastrointestinal Diseases (5)  ·  Gastrointestinal Neoplasms (5)  ·  Intestinal Diseases (5)  ·  Intestinal Neoplasms (5)  ·  Colonic Diseases (4)  ·  Rectal Diseases (4)  ·  Cardiovascular Diseases (3)  ·  Nutritional and Metabolic Diseases (3)  ·  Pathological Conditions, Signs and Symptoms (3)  ·  Vascular Diseases (3)  ·  Behavior (2)

Interventions

FOLFOXIRI protocol (3)  ·  Fluorouracil (3)  ·  Irinotecan (3)  ·  Oxaliplatin (3)  ·  Cisplatin (2)  ·  Docetaxel (2)  ·  Aztreonam (1)  ·  Bevacizumab (1)  ·  Biopsy (1)  ·  Capecitabine (1)  ·  Denosumab (1)  ·  Diphosphonates (1)  ·  Drug Delivery Systems (1)  ·  Erlotinib Hydrochloride (1)  ·  Hospitalization (1)

Sponsors

China Medical University, China (3)  ·  Beijing Anzhen Hospital (2)  ·  Anna Vlasova (1)  ·  Centre for Addiction and Mental Health (1)  ·  Centre hospitalier de l'Université de Montréal (CHUM) (1)  ·  Chang Gung Memorial Hospital (1)  ·  Chinese PLA General Hospital (1)  ·  European Society of Anaesthesiology (1)  ·  First Affiliated Hospital of Wenzhou Medical University (1)  ·  Fudan University (1)  ·  Istanbul Sabahattin Zaim University (1)  ·  Karl Landsteiner Insitute for Nephrology and Haemato-Oncology (1)  ·  Kinderkrankenhaus auf der Bult (1)  ·  National Cancer Institute (NCI) (1)  ·  National Cheng-Kung University Hospital (1)

Countries

China (11)  ·  United States (4)  ·  Canada (2)  ·  Sweden (2)  ·  Austria (1)  ·  Brazil (1)  ·  Germany (1)  ·  Russia (1)  ·  Taiwan (1)  ·  Turkey (Türkiye) (1)

Top investigators

Jingdong Zhang (2)  ·  Anna Vlasova, PhD, MD (1)  ·  Bing Bing, PhD (1)  ·  Chih-Hsing Wu, MD (1)  ·  Clint T Allen, M.D. (1)  ·  Gary E. Rosenthal, MD (1)  ·  Gary J Remington, MD, PhD (1)  ·  Jaime M Moore, MD, MPH (1)  ·  Jiayu Wang, doctor (1)  ·  Jun Jia, MD (1)  ·  Karin Manhem, Prof, MD (1)  ·  Leonardo O Reis, MD, MSc, PhD (1)  ·  Liang-An Chen, M.D., Ph.D. (1)  ·  Martin F Wiesholzer, MD (1)  ·  Max Bell, MD/PhD (1)

Results publications

PMID 10440432, PMID 10447337, PMID 10738843, PMID 10797074, PMID 11033734, PMID 11170945, PMID 15342610, PMID 16080072, PMID 16505659, PMID 17279026, PMID 19017859, PMID 19636035, PMID 21685488, PMID 23537581, PMID 24322269, PMID 24909419, PMID 24978045, PMID 26182689, PMID 28248319, PMID 31073101, PMID 3209527, PMID 33601296, PMID 39916820, PMID 8591695

NIH funding

2025 (1), P30DK048520 (1)